Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications; D010096:Oxprenolol / Q000627:therapeutic use; D005082:Physical Exertion; D011433:Propranolol / Q000627:therapeutic use*; D011802:Quinidine / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects; D013015:Sotalol / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D011941:Receptors, Adrenergic; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D011802:Quinidine; D007545:Isoproterenol